Development and Application of a Decision-Making Aid Tool for Amputation Surgery in Diabetic Foot Patients Based on the Ottawa Decision Support Framework
Impact of Decision Support Tools on Amputation Decisions in Diabetic Foot Patients: A Quasi-Experimental Study
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
To verify whether amputation decision-making aids can alleviate the decisional dilemma in diabetic foot patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2025
CompletedFirst Posted
Study publicly available on registry
November 26, 2025
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2026
November 26, 2025
November 1, 2025
5 months
November 19, 2025
November 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decisional Conflict Scale,DCS
The scale consists of 16 items and has undergone standardized conversion, with a total score of 100 points. A lower score indicates a lower level of decisional conflict in patients. A score \>25 suggests the presence of decisional conflict during the decision-making process, while a score \>37.5 indicates potential delays in decision-making
When the patient was admitted to the hospital;Three days post-surgery;One month postoperatively
Secondary Outcomes (3)
The Control Preference Scale,CPS
When the patient was admitted to the hospital;Three days post-surgery;One month postoperatively
The Satisfaction with Decision Scale,SWD
Three days post-surgery ;One month postoperatively
Decision Regret Scale,DRS
Three days post-surgery;One month postoperatively
Study Arms (2)
Experimental group
ACTIVE COMPARATORIn addition to receiving routine clinical consultations and nursing care identical to the control group, the intervention group will utilize an electronic decision-making aid for diabetic foot amputation. We will design this electronic tool and deliver it to participants via a WeChat Mini Program. Patients will be instructed to spend no more than 60 minutes using the tool, with researchers supervising their sessions and providing assistance as needed. During the study period, the electronic decision-making aid will remain confidential and accessible only to the intervention group, with restricted access for physicians and non-intervention patients.
Control group
PLACEBO COMPARATORPatients received routine clinical consultation and nursing care before and after random assignment.
Interventions
In addition to receiving routine clinical consultations and nursing care identical to the control group, the intervention group will utilize an electronic decision-making aid for diabetic foot amputation. We will design this electronic tool and deliver it to participants via a WeChat Mini Program. Patients will be instructed to spend no more than 60 minutes using the tool, with researchers supervising their sessions and providing assistance as needed. During the study period, the electronic decision-making aid will remain confidential and accessible only to the intervention group, with restricted access for physicians and non-intervention patients.
Patients received routine clinical consultation and nursing care before and after random assignment.
Eligibility Criteria
You may qualify if:
- Diabetic foot ulcers with Wagner grade 4 or higher gangrene. Diabetic foot ulcers with Wagner grade 3 accompanied by severe infection or systemic symptoms; severe local infections, or chronic osteomyelitis causing functional impairment of the limb.
- Patients with lower extremity vascular disease showing progression despite systemic treatment.
- IWGDF stage 3 severe infections (characterized by loss of protective sensation or peripheral arterial disease, with at least one of the following: history of foot ulcer, lower limb amputation, or end-stage renal disease).
You may not qualify if:
- History of psychiatric disorders with inability to cooperate during communication.
- Concomitant severe complications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shiwen Honglead
- Sir Run Run Shaw Hospitalcollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- ShiWen Hongª (MS)nursing department, sir run run shaw hospital,zhejiang university school of medicine.Hangzhou, Zhejiang Province, China
Study Record Dates
First Submitted
November 19, 2025
First Posted
November 26, 2025
Study Start
May 1, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 31, 2026
Last Updated
November 26, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share